XOSPATA (gilteritinib fumarate)


Drug overview for XOSPATA (gilteritinib fumarate):

Generic name: gilteritinib fumarate (GIL-te-RI-ti-nib)
Drug class: Antineoplastic - Protein-Tyrosine Kinase Inhibitors
Therapeutic class: Antineoplastics

Gilteritinib, an inhibitor of multiple receptor tyrosine kinases, including fms-like tyrosine kinase-3 (Flt-3), is an antineoplastic agent.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • XOSPATA 40 MG TABLET
    XOSPATA 40 MG TABLET
The following indications for XOSPATA (gilteritinib fumarate) have been approved by the FDA:

Indications:
Acute myeloid leukemia with FMS-like tyrosine kinase-3 (FLT3) mutation


Professional Synonyms:
FLT3 mutated AML
FLT3 mutation-positive acute myeloid leukemia
FLT3-mutant AML